A study of the safety of a new medicine (DCLL9718S) in patients with a type of blood cancer (acute myeloid leukemia)

A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for Intensive Induction Chemotherapy

Cancer
Leukemia

Results
Download
Print

Study results

LPS GO39902 Final Results July 2020 English (PDF, 0.1 MB)

LPS GO39902 Final Results July 2020 Canada French (PDF, 0.1 MB)

LPS GO39902 Final Results July 2020 US Spanish (PDF, 0.1 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A study of the safety of a new medicine (DCLL9718S) in patients with a type of blood cancer (acute myeloid leukemia)

Study results

LPS GO39902 Final Results July 2020 English (PDF, 0.1 MB)

LPS GO39902 Final Results July 2020 Canada French (PDF, 0.1 MB)

LPS GO39902 Final Results July 2020 US Spanish (PDF, 0.1 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A study of the safety of a new medicine (DCLL9718S) in patients with a type of blood cancer (acute myeloid leukemia)

For the latest version of this information please go to www.forpatients.roche.com